Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Planned Parenthood Clinics in Two States to Offer Advance Supply of Abortion Pills

Planned Parenthood clinics in Washington state and Hawaii will now provide patients with abortion pills in advance. The pills, mifepristone and misoprostol, can be stored for future use if a patient chooses to terminate a pregnancy.

06/12/2026 · Kentucky edition

Advertisement

Advertisement

Planned Parenthood clinics in Washington state and Hawaii will begin offering patients a supply of mifepristone and misoprostol to keep on hand. These medications are used to medically terminate pregnancies.

Patients can obtain the pills during a regular consultation with a Planned Parenthood health care provider. If the patient later experiences an unwanted pregnancy, they can then use the medication without requiring an immediate appointment.

Planned Parenthood representatives stated the new service aims to improve access to reproductive healthcare. The organization has not yet released details about cost or specific eligibility requirements.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102445 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Kentucky

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Kentucky

health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Supreme Court Declines Cases on 'Let's Go Brandon' Apparel, Felon Gun Rights, and Vaccine Mandates

The Supreme Court initiated its 2026-27 term by issuing an order list from its September 28 private conference. Justices denied review in hundreds of cases, including those concerning student free speech, Second Amendment challenges for felons, and COVID-19 vaccine requirements.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories